Anterior chamber fibrinoid syndrome after cataract extraction in a patient on ibrutinib for B-cell chronic lymphocytic leukemia: a case report and review of the literature

BACKGROUND: Ibrutinib is a tyrosine kinase inhibitor commonly used in patients with chronic lymphocytic leukemia. Based on the published literature, it has a very sound ophthalmologic safety profile. In the following, we describe a case of anterior chamber fibrinoid syndrome in a patient on ibrutini...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolomeyer, Anton M., Hwang, Christopher K., Kim, Benjamin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238337/
https://www.ncbi.nlm.nih.gov/pubmed/30442199
http://dx.doi.org/10.1186/s13256-018-1822-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238337/
https://www.ncbi.nlm.nih.gov/pubmed/30442199
http://dx.doi.org/10.1186/s13256-018-1822-9

Ejemplares similares